Thus, a functional vaccination strategy with the MelARV Env target sequence could in principle be applied to many different murine cancer types, considering the very broad expression of MuLV Env-derived gene products in diverse tumor cell lines [16]. The gene discussed is ERVW-1; the disease is neoplasm.